Literature DB >> 15047517

Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms.

Niels Bagge1, Morten Hentzer, Jens Bo Andersen, Oana Ciofu, Michael Givskov, Niels Høiby.   

Abstract

The development of resistance to beta-lactam antibiotics is a problem in the treatment of chronic Pseudomonas aeruginosa infection in the lungs of patients with cystic fibrosis. The main resistance mechanism is high-level expression of the chromosomally encoded AmpC beta-lactamase of P. aeruginosa cells growing in biofilms. Several genes have been shown to influence the level of ampC expression, but little is known about the regulation of ampC expression in P. aeruginosa biofilms. To study the expression of ampC in P. aeruginosa biofilms, we constructed a reporter that consisted of the fusion of the ampC promoter to gfp(ASV) encoding an unstable version of the green fluorescent protein. In vitro biofilms of P. aeruginosa were exposed to the beta-lactam antibiotics imipenem and ceftazidime. Sub-MICs of imipenem significantly induced the monitor system of the biofilm bacteria in the peripheries of the microcolonies, but the centers of the microcolonies remained uninduced. However, the centers of the microcolonies were physiologically active, as shown by experiments with another monitor construction consisting of an arabinose-inducible promoter fused to gfp(ASV). The whole biofilm was induced in the presence of increased imipenem concentrations. Ceftazidime induced the monitor system of the biofilm bacteria as well, but only bacteria in the peripheries of the microcolonies were induced in the presence of even very high concentrations. The experiments illustrate for the first time the dynamic and spatial distributions of beta-lactamase induction in P. aeruginosa cells growing in biofilms. Thus, our experiments show that P. aeruginosa cells growing in biofilms constitute a heterogeneous population unit which may create different antibiotic-selective environments for the bacteria in the biofilm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047517      PMCID: PMC375278          DOI: 10.1128/AAC.48.4.1168-1174.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

Review 1.  Pathogenesis of cystic fibrosis.

Authors:  C Koch; N Høiby
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

Review 2.  Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.

Authors:  R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1998-07       Impact factor: 2.803

3.  Biofilms and beta-lactam activity.

Authors:  P Gilbert; M R Brown
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

4.  The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide.

Authors:  H Dietz; D Pfeifle; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

5.  New unstable variants of green fluorescent protein for studies of transient gene expression in bacteria.

Authors:  J B Andersen; C Sternberg; L K Poulsen; S P Bjorn; M Givskov; S Molin
Journal:  Appl Environ Microbiol       Date:  1998-06       Impact factor: 4.792

6.  Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamases.

Authors:  G H Dibdin; S J Assinder; W W Nichols; P A Lambert
Journal:  J Antimicrob Chemother       Date:  1996-11       Impact factor: 5.790

Review 7.  Biofilms, the customized microniche.

Authors:  J W Costerton; Z Lewandowski; D DeBeer; D Caldwell; D Korber; G James
Journal:  J Bacteriol       Date:  1994-04       Impact factor: 3.490

8.  Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

Authors:  B Frederiksen; S Lanng; C Koch; N Høiby
Journal:  Pediatr Pulmonol       Date:  1996-03

9.  Theoretical aspects of antibiotic diffusion into microbial biofilms.

Authors:  P S Stewart
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

10.  Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.

Authors:  O Ciofu; B Giwercman; S S Pedersen; N Høiby
Journal:  APMIS       Date:  1994-09       Impact factor: 3.205

View more
  41 in total

1.  Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.

Authors:  Laura L Bowler; George G Zhanel; T Blake Ball; Laura L Saward
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

2.  Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro.

Authors:  H M H N Bandara; A Harb; D Kolacny; P Martins; H D C Smyth
Journal:  AAPS PharmSciTech       Date:  2014-08-26       Impact factor: 3.246

3.  Membrane vesicles: an overlooked component of the matrices of biofilms.

Authors:  Sarah R Schooling; Terry J Beveridge
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

Review 4.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

5.  The synthetic human beta-defensin-3 C15 peptide exhibits antimicrobial activity against Streptococcus mutans, both alone and in combination with dental disinfectants.

Authors:  Ki Bum Ahn; A Reum Kim; Kee-Yeon Kum; Cheol-Heui Yun; Seung Hyun Han
Journal:  J Microbiol       Date:  2017-09-28       Impact factor: 3.422

Review 6.  Biofilm-specific antibiotic tolerance and resistance.

Authors:  I Olsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-29       Impact factor: 3.267

Review 7.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

8.  Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.

Authors:  Wang Hengzhuang; Hong Wu; Oana Ciofu; Zhijun Song; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

9.  New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.

Authors:  Janus A J Haagensen; Davide Verotta; Liusheng Huang; Alfred Spormann; Katherine Yang
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

Review 10.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.